GlassScriptPhysician profile
Varin Sachhathep
NPI 1083218507
$6,475.75
in general payments reported to CMS, 2019-2025
28 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $64.48 · 2022: $1,278 · 2023: $911 · 2024: $1,595 · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,133.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,446.81 | 2022-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $592.57 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Inspire Medical Systems, INC. | $533.86 | 2024-2025 | Inspire |
| Genzyme Corporation | $470.71 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.11 | 2022-2025 | Ofev, Jascayd |
| Amgen INC. | $401.98 | 2022-2025 | Tezspire |
| Electromed, INC. | $360.51 | 2023-2025 | Smartvest |
| Grifols USA, LLC | $338.35 | 2021-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $296.11 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $292.05 | 2021-2024 | Yupelri |
| Baxter Healthcare | $223.50 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $222.79 | 2022-2025 | Arikayce |
| Pulmonx Corporation | $167.95 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Actelion Pharmaceuticals US, INC. | $103.92 | 2023-2024 | Opsumit, Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $97.56 | 2023-2025 | Glassia |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $91.93 | 2024-2025 | Acthar |
| Merck Sharp & Dohme LLC | $91.55 | 2023-2024 | Winrevair |
| Harmony Biosciences LLC | $53.88 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $51.99 | 2023-2024 | Purified Cortrophin Gel |
| Verona Pharma, INC. | $44.20 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $29.87 | 2025 | |
| Axsome Therapeutics, INC. | $24.75 | 2025 | Sunosi |
| Tactile Systems Technology INC | $24.48 | 2024 | Entre Plus, Flexitouch Plus |
| Hikma Pharmaceuticals USA | $24.31 | 2025 | Ryaltris |
| Inogen, INC. | $20.90 | 2022 | |
| Genentech USA, INC. | $20.81 | 2022 | |
| Viatris Specialty LLC | $20.17 | 2025 | Yupelri |
| Jazz Pharmaceuticals INC. | $20.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varin Sachhathep listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.